IBTimes -
19 Aug 2014 05:34
Researchers at Columbia University Medical Center say a drug used to treat bone marrow cancer can restore hair for people suffering from alopecia areata. The researchers found ruxolitinib, which already has been approved by the Food and Drug Administration, produced total hair regrowth within five months and the hair persisted after treatment stopped.
Share this Article
Comment on this Article
Please to comment